Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Pedestrian Crash on Crenshaw Boulevard


SUV Hits Victim in Fatal Torrance Accident 

Pedestrian Fatality 2

Torrance, CA (February 26, 2020) – A man was killed in a pedestrian crash in Torrance. The fatal accident occurred on the evening of February 26 on Crenshaw Boulevard.

A 55-year-old man from Torrance was driving a Jeep Grand Cherokee when he hit a pedestrian in the 24200 block of Crenshaw Boulevard. The person was crossing the road at the time of the crash. The pedestrian, an unidentified man, died at the accident scene. The driver was not injured.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Torrance

#90505


April 24, 2020

Major Injuries in Crash on Interstate 5 Near Sutterville Road

Motorcycle, SUV Collide in Sacramento Accident...


May 8, 2020

Donatus Okhomina Killed in Transformer Accident on East Meadow Drive

Victim Was Working for City of Palo Alto in Fatal Accident...


April 15, 2020

1 Injured in Crash on Interstate 10 Near Citrus Avenue

2 Vehicles Collide in Hit and Run Accident in Fontana...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.